Hudson Bay Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $188M | Buy |
|
|||||
|
2021
Q1 | $153M | Buy |
|
|||||
|
2020
Q4 | $56.9M | Buy |
|
|||||
|
2020
Q3 | $27M | Sell |
|
|||||
|
2020
Q2 | $27.2M | Buy |
|
|||||
|
2020
Q1 | $18M | Buy |
|
|||||
|
2019
Q4 | $20.9M | Buy |
|
|||||
|
2019
Q3 | $16.2M | Buy |
|
|||||
|
2019
Q2 | $7.2M | Buy |
|
|||||
|
2019
Q1 | $3.38M | Sell |
|
|||||
|
2018
Q4 | $8.41M | Buy |
|
|||||
|
2018
Q3 | $8.37M | Buy |
|
|||||
|
2018
Q2 | $3.73M | Sell |
|
|||||
|
2018
Q1 | $6.69M | Sell |
|
|||||
|
2017
Q4 | $8.37M | Buy |
|
|||||
|
2017
Q3 | $5.61M | Sell |
|
|||||
|
2017
Q2 | $8.52M | Sell |
|
|||||
|
2017
Q1 | $17.6M | Buy |
|
|||||
|
2016
Q4 | $12.8M | Buy |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $6.25M | Sell |
|
|||||
|
2014
Q1 | $11.4M | Sell |
|
|||||
|
2013
Q4 | $10.5M | Sell |
|
|||||
|
2013
Q3 | $20.7M | Buy |
|